Vijaypd Ceutical Ltd
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.[1]
- Market Cap ₹ 167 Cr.
- Current Price ₹ 85.7
- High / Low ₹ 85.8 / 35.0
- Stock P/E 39.2
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 20.4 %
- ROE 24.8 %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Electrical Equipment Heavy Electrical Equipment
Part of Nifty SME Emerge
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 51 | 59 | 117 | |
| 50 | 54 | 109 | |
| Operating Profit | 1 | 5 | 9 |
| OPM % | 3% | 8% | 7% |
| 2 | 0 | 1 | |
| Interest | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 1 |
| Profit before tax | 0 | 3 | 7 |
| Tax % | 49% | 40% | 27% |
| 0 | 2 | 5 | |
| EPS in Rs | 3.42 | ||
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 98% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 189% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 22% |
| Last Year: | 25% |
Balance Sheet
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|
| Equity Capital | 0.00 | 1 | 14 | 14 |
| Reserves | 5 | 6 | 18 | 21 |
| 26 | 24 | 22 | 20 | |
| 2 | 2 | 3 | 4 | |
| Total Liabilities | 33 | 33 | 57 | 59 |
| 3 | 2 | 8 | 8 | |
| CWIP | 0 | 0 | 0 | 1 |
| Investments | 0 | 0 | 0 | 0 |
| 30 | 31 | 48 | 50 | |
| Total Assets | 33 | 33 | 57 | 59 |
Cash Flows
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 0 | 3 | -8 | |
| -0 | 13 | -1 | |
| -0 | -2 | -2 | |
| Net Cash Flow | 0 | 14 | -11 |
| Free Cash Flow | 0 | 3 | -9 |
| CFO/OP | 38% | 60% | -80% |
Ratios
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 62 | 69 | 74 |
| Inventory Days | 31 | 29 | 43 |
| Days Payable | 15 | 5 | 8 |
| Cash Conversion Cycle | 78 | 92 | 109 |
| Working Capital Days | -84 | -60 | 59 |
| ROCE % | 15% | 20% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Inventory Levels Days |
|
|||
| Net Fixed Asset Turnover Times |
||||
| Employee Count Number |
||||
| Number of Customers Number |
||||
| Number of SKUs Number |
||||
| Number of Suppliers Number |
||||
| Warehousing Area Sq. Ft. |
||||
Extracted by Screener AI
Documents
Announcements
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
13 April 2026 - Company states corporate governance provisions are not applicable for quarter ended 31 March 2026.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
13 April 2026 - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.
-
Acquisition
8 April 2026 - Vijaypd Ceutical approved 100% acquisition of Siddharth Drugs for Rs 7.01 crore, completion by 14 April 2026.
-
Trading Window
28 March 2026 - Trading window closed from April 1, 2026 until 48 hours after FY2026 audited results.
-
Outcome of Board Meeting
16 March 2026 - Board appointed Sodha & Associates as Internal Auditor and Nikunj Kanabar & Associates as Secretarial Auditor on March 16, 2026.
Business Profile[1]
The company is a distributor and supplier of pharmaceutical and consumer goods. The company acts as a representative, dealer, agent, stockist, supplier, trader, and packer for pharmaceutical and wellness products. It operates across Western Suburban Mumbai, South Mumbai, Ratnagiri, Aurangabad, and Akola, serving 2,109+ pharmacies, clinics, and nursing homes as of March 31, 2025.